The revised framework directs drug inspectors to prepare monthly and annual sampling plans covering the entire jurisdiction.

India’s central drug regulator flagged 169 medicine samples as Not of Standard Quality during April inspections, while one ...

Reflecting continuing concerns over medicine quality and regulatory compliance in India's pharmaceutical market, the Central ...

New Delhi, May 26 (PTI) The Central Drugs Standard Control Organisation (CDSCO) has issued revised regulatory guidelines for sampling of drugs, cosmetics and medical devices, mandating wider ...

CDSCO flags one batch of a liver drug as spurious and identifies 169 drugs and formulations as not of standard quality during ...

According to routine regulatory surveillance, the list of not of standard quality (NSQ) and spurious drugs is displayed on ...

Indian regulators tighten drug quality oversight as substandard and spurious medicine cases rise in five years: Shardul Nautiyal, Mumbai Thursday, May 14, 2026, 08:00 Hrs [IST] Th ...

The Central Drugs Standard Control Organisation (CDSCO) has issued an alert regarding a batch of Ursodeoxycholic Acid Tablets ...

Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, the ...

In a late-night operation, the Haryana Food and Drugs Administration (FDA), in coordination with the police, busted an alleged racket involving spurious Mounjaro KwikPen injections and arrested two ...

ISLAMABAD, April 6 Health Minister Makhdoom Shahabuddin told the Senate on Tuesday that only 0.45 per cent of 50,000 drug samples tested by his ministry had been found to be spurious. Responding to ...